Delivery Order SPE2DB22D3009-SPE2DB25FAV83

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $9.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,657.30, is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract has an ultimate completion date of April 23, 2025 and was awarded on April 22, 2025. AmerisourceBergen Drug Corp is a for-profit organization registered in SAM.gov since 2002 and has a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,378.37, is for the delivery of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract has an ultimate completion date of April 8, 2025 and is a firm fixed-price delivery order. This contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a ceiling value of $1,856.46 and a period of performance through January 25, 2024. The contract was awarded on a firm fixed-price basis without any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,376.76, is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract has a firm fixed price and a performance period through March 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract, valued at $3,373.43, is for the supply of SYNVISC-ONE SYRINGE 6ML, a pharmaceutical product. The contract has an ultimate completion date of August 26, 2024 and is a firm-fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SYNVISC-ONE SYRINGE 6ML medical products. The contract has a ceiling value of $13,456.85 and an ultimate completion date of August 29, 2024. It is a firm fixed-price contract and is not designated as a set-aside. AmerisourceBergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $9,560.77. The order is for SYNVISC-ONE SYRINGE 6ML, a pharmaceutical product. The contract has an ultimate completion date of November 27, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division that serves as a primary vehicle for providing a wide range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SYNVISC-ONE SYRINGE 6ML, a specialty medical product. The firm-fixed-price contract, valued at $3,503.46, has a period of performance through November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a pharmaceutical product. The contract has a firm fixed price of $2,229.80 and a completion date of September 27, 2024. This contract is not set aside for a specific business type. Amerisourcebergen Drug Corp's Corporate Office division holds this contract, which is a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SYNVISC-ONE syringes. The contract, valued at $1,886.72, has a completion date of July 25, 2024. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, valued up to $999,999,999 and $750,000...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB25FAV83
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,095.93, is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 23, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, particularly the DLA. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026, enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 7/22/25, 9:52 AM